Literature DB >> 17554641

[Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].

M Cornberg1, U Protzer, M M Dollinger, J Petersen, H Wedemeyer, T Berg, W Jilg, A Erhardt, S Wirth, P Schirmacher, W E Fleig, M P Manns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554641     DOI: 10.1055/s-2007-963232

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  14 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 2.  [Sexually transmissible hepatitis viruses].

Authors:  S Schaefer
Journal:  Hautarzt       Date:  2009-06       Impact factor: 0.751

3.  Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Authors:  Ingmar Mederacke; Birgit Bremer; Benjamin Heidrich; Janina Kirschner; Katja Deterding; Thomas Bock; Karsten Wursthorn; Michael P Manns; Heiner Wedemeyer
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

5.  [Prevention of virus hepatitis A to E].

Authors:  M Cornberg; M P Manns
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

6.  Treatment options for hepatitis delta virus infection.

Authors:  Benjamin Heidrich; Michael P Manns; Heiner Wedemeyer
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 7.  [Viral hepatitis B und C].

Authors:  Markus Reiser
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 8.  [New data and recommendations of antiviral therapy of chronic hepatitis B and C].

Authors:  C Niederau
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743

9.  [Diagnostics and therapy of hepatitis].

Authors:  C P Strassburg; M Cornberg
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

10.  The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.

Authors:  Hans Ludger Tillmann
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.